Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥222.15B | 14.8x | 0.04 | JP¥1,712 | -7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥192.93B | -64x | 18.18 | JP¥2,670 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -53.7% Downside | Upgrade to Pro+ | |
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥124.48B | 113.1x | -1.24 | JP¥2,476 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥97.42B | -1,830x | 18.54 | JP¥783 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥56.54B | 11.5x | -1.04 | JP¥1,361 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥52.96B | -40.6x | -1.22 | JP¥2,330 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥32.37B | -6.7x | -0.52 | JP¥320 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥27.4B | 10x | -0.24 | JP¥948 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥20.34B | -0.6x | 0 | JP¥62 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥15.52B | -8.1x | JP¥222 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥14.56B | -12.8x | -0.47 | JP¥133 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥10.54B | -6.8x | 0.23 | JP¥206 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.77B | 48.1x | 0.19 | JP¥374 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.49B | -7.9x | -0.32 | JP¥140 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥9.39B | -14.7x | -0.38 | JP¥133 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥8.81B | JP¥244 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.97B | -8.9x | 0.2 | JP¥999 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥7.94B | -1.4x | JP¥31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.73B | -29x | 0.21 | JP¥299 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.45B | -7.5x | -0.35 | JP¥152 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥6.34B | -0.22 | JP¥23 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.84B | -14.1x | JP¥133 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.74B | -6.3x | -0.29 | JP¥816 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.52B | -2.7x | -0.06 | JP¥74 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.4B | -8.7x | -0.22 | JP¥136 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥5.12B | 0.03 | JP¥265 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.71B | -2.8x | 0.08 | JP¥106 | 3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.2B | 0.03 | JP¥640 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥4.01B | 15.2x | -2.41 | JP¥684 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.79B | -3.4x | -0.46 | JP¥84 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.71B | JP¥42 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥3.47B | -3.2x | -0.19 | JP¥103 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | JP¥1.44B | -10.5x | 0.04 | JP¥355 | -11.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |